Lucie M. Turcotte
Expertise in
3
conditions

Dr. Lucie M. Turcotte

Pediatric Hematology Oncology
2450 Riverside Avenue, Floor 9, 
Minneapolis, MN 
Accepting New Patients
Expertise in
3
conditions
2450 Riverside Avenue, Floor 9, 
Minneapolis, MN 

Overview

Lucie Turcotte is a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota.

Dr. Turcotte is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), and Langerhans Cell Histiocytosis.

Dr. Turcotte is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015 and Pediatrics: American Board Of Pediatrics, 2010. She is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 3 clinical trials. Dr. Turcotte is currently accepting new patients.

Specialties

Pediatric Hematology Oncology

Licenses

Pediatrics in MN

Board Certifications

Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015
Pediatrics: American Board Of Pediatrics, 2010

Fellowships

University of Minnesota Pediatric Hem Onc, Pediatric Hematology-Oncology - 2013

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford Health
  • HMO
  • PPO
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

M Health Fairview Journey Pediatric Specialty Clinic
2450 Riverside Avenue, Floor 9, Minneapolis, MN 55454

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

StepByStep: A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
StepByStep: A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2026
Intervention Type: Other, Behavioral, Device
Study Phase: Phase 3
A Randomized Web-Based Physical Activity Intervention Among Children and Adolescents With Cancer
A Randomized Web-Based Physical Activity Intervention Among Children and Adolescents With Cancer
Enrollment Status: Completed
Publish Date: July 24, 2026
Intervention Type: Other, Device
Study Phase: Phase 3
A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes (LMP-TC) in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)
A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes (LMP-TC) in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Drugs: Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes, Rituximab
Study Phase: Phase 2
View 2 Less Clinical Trials

100 Total Publications

The influence of elevated body mass index on protein expression in pediatric b-cell acute lymphoblastic leukemia.
The influence of elevated body mass index on protein expression in pediatric b-cell acute lymphoblastic leukemia.
Journal: Pediatric hematology and oncology
Published: April 28, 2026
Similar Doctors
Expertise in
14
conditions
Dr. Margaret L. Macmillan
Pediatrics | Pediatric Hematology Oncology
Expertise in
14
conditions
Dr. Margaret L. Macmillan
Pediatrics | Pediatric Hematology Oncology
Referral may be required

M Health Fairview Center For Pediatric Blood And Marrow Transplant And Celluar Therapy

Journey Clinic Riverside East 9th, Floor 2450 Riverside Ave, 
Minneapolis, MN 
 (0.3 miles away)
612-365-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Margaret Macmillan is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Macmillan is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Congenital Aplastic Anemia, Fanconi Anemia, Graft Versus Host Disease (GvHD), Aplastic Anemia, and Bone Marrow Transplant. Dr. Macmillan is currently accepting new patients.

Expertise in
16
conditions
Dr. Paul J. Orchard
Transplant Surgery | Pediatrics | Pediatric Hematology Oncology
Expertise in
16
conditions
Dr. Paul J. Orchard
Transplant Surgery | Pediatrics | Pediatric Hematology Oncology
Referral may be required

M Health Fairview Center For Pediatric Blood And Marrow Transplant And Celluar Therapy

Journey Clinic Riverside East 9th, Floor 2450 Riverside Ave, 
Minneapolis, MN 
 (0.3 miles away)
612-365-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Paul Orchard is a Transplant Surgeon and a Pediatrics provider practicing medicine in Minneapolis, Minnesota. Dr. Orchard is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Adrenoleukodystrophy (ALD), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Mucopolysaccharidoses (MPS), Bone Marrow Transplant, and Osteotomy. Dr. Orchard is currently accepting new patients.

Expertise in
15
conditions
Dr. Troy C. Lund
Pediatrics | Pediatric Hematology Oncology
Expertise in
15
conditions
Dr. Troy C. Lund
Pediatrics | Pediatric Hematology Oncology
Referral may be required

M Health Fairview Journey Pediatric Specialty Clinic

2450 Riverside Avenue, Building 9 EAST, 
Minneapolis, MN 
 (0.1 miles away)
612-365-8100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Troy Lund is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Lund is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Adrenoleukodystrophy (ALD), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Mucopolysaccharidoses (MPS), Alpha Mannosidosis, and Bone Marrow Transplant. Dr. Lund is board certified in Pediatrics: American Board Of Pediatrics, 2007 and Pediatric Hematology-Oncology: American Board Of Pediatrics, 2011. Dr. Lund is currently accepting new patients.

Frequently Asked Questions about Dr. Lucie M. Turcotte

How do I make an appointment with Dr. Lucie M. Turcotte?

You can book an appointment with Dr. Lucie M. Turcotte by calling their office at 612-365-8100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lucie M. Turcotte a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lucie M. Turcotte is classified as an Advanced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lucie M. Turcotte specialize in?

While Dr. Lucie M. Turcotte is a Pediatric Hematology Oncology, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Leukemia, and Graft Versus Host Disease (GvHD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.

Does Dr. Lucie M. Turcotte participate in research or clinical trials?

Yes. Dr. Lucie M. Turcotte has published 100 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Lucie M. Turcotte's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Lucie M. Turcotte accept my insurance?

Dr. Lucie M. Turcotte accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 612-365-8100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Turcotte's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile